Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of three radioligands, selenium-75, iodine-125, and tritium, in the radioimmunoassay of methotrexate

Journal Article · · Clin. Chem.; (United States)
OSTI ID:6453433
Radioimmunoassays for methotrexate are described, involving use of a rabbit antiserum to a conjugate of the drug and bovine serum albumin and the drug labeled with tritium, selenium-75, or iodine-125. Of the two gamma emitters, the /sup 75/Se-labeled drug was prepared by the Radiochemical Centre, Amersham, England and the /sup 125/I-labeled drug in the laboratory, by the Chloramine T iodination technique. The stability of labels with both methods allows use of the faster, cheaper, and simpler gamma-counting techniques, with results available after 3 h. All three methods have acceptable sensitivity, accuracy, precision, and reproducibility, and are specific for methotrexate, with no significant interference from naturally occurring folates or leucovorin. The assays in which the gamma emitters are used have significant practical advantages over the beta emitter and are much better suited to automation and clinical application. The main advantage of /sup 75/Se-labeled methotrexate is its longer half-life, 121 days, as compared with 60 days for /sup 125/I.
OSTI ID:
6453433
Journal Information:
Clin. Chem.; (United States), Journal Name: Clin. Chem.; (United States) Vol. 24:9; ISSN CLCHA
Country of Publication:
United States
Language:
English